These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 32129882)
21. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer. Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of immune cell infiltration within gallbladder cancer. Nakakubo Y; Miyamoto M; Cho Y; Hida Y; Oshikiri T; Suzuoki M; Hiraoka K; Itoh T; Kondo S; Katoh H Br J Cancer; 2003 Nov; 89(9):1736-42. PubMed ID: 14583778 [TBL] [Abstract][Full Text] [Related]
23. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression. Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856 [TBL] [Abstract][Full Text] [Related]
25. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features. Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M Front Immunol; 2021; 12():730746. PubMed ID: 34630409 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status. Chung YR; Kim HJ; Jang MH; Park SY Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931 [TBL] [Abstract][Full Text] [Related]
27. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Fukunaga A; Miyamoto M; Cho Y; Murakami S; Kawarada Y; Oshikiri T; Kato K; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Itoh T; Morikawa T; Okushiba S; Kondo S; Katoh H Pancreas; 2004 Jan; 28(1):e26-31. PubMed ID: 14707745 [TBL] [Abstract][Full Text] [Related]
29. Pancreaticogastrostomy: A Safe Option in Pancreaticoduodenectomy for Pancreatic Head and Periampullary Neoplasms. Noor MA; Hanif F; Shakeel O; Bari H J Coll Physicians Surg Pak; 2020 Jan; 30(1):51-56. PubMed ID: 31931933 [TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317 [TBL] [Abstract][Full Text] [Related]
31. Dissecting the spatial heterogeneity of different immune cell subsets in non-small cell lung cancer. Jurmeister P; von Laffert M; Jöhrens K Pathol Res Pract; 2020 May; 216(5):152904. PubMed ID: 32143905 [TBL] [Abstract][Full Text] [Related]
32. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer. Wu J; Wang Y; Jiang Z J Gastrointest Cancer; 2021 Mar; 52(1):150-159. PubMed ID: 32077004 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750 [TBL] [Abstract][Full Text] [Related]
34. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. Uppal A; Dehal A; Chang SC; Barrak D; Naeini Y; Jalas JR; Bilchik AJ J Gastrointest Surg; 2020 Jan; 24(1):28-38. PubMed ID: 31625020 [TBL] [Abstract][Full Text] [Related]
35. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors. Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S Front Immunol; 2021; 12():654660. PubMed ID: 33968055 [TBL] [Abstract][Full Text] [Related]
36. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833 [TBL] [Abstract][Full Text] [Related]
37. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Emmrich J; Weber I; Nausch M; Sparmann G; Koch K; Seyfarth M; Löhr M; Liebe S Digestion; 1998; 59(3):192-8. PubMed ID: 9643678 [TBL] [Abstract][Full Text] [Related]
40. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]